Focus on cannabinoids and synthetic cannabinoids

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• The endocannabinoid system regulates numerous physiological processes.
• Synthetic cannabinoids (SCs) are increasingly prevalent, with effects often exceeding those of natural cannabis.
• Understanding SCs is crucial due to their complex interactions with cannabinoid receptors.

Purpose of the Study:

• To review the emerging information on synthetic cannabinoids.
• To explore the physiological roles of the endocannabinoid system.
• To assess the risks and potential therapeutic value of SCs.

Main Methods:

• Literature review of synthetic cannabinoid research.
• Analysis of pharmacological data on cannabinoid receptor interactions.
• Examination of clinical reports on cannabinoid poisoning and abuse.

Main Results:

• SCs exhibit full agonist activity and higher affinity for cannabinoid receptors compared to cannabis.
• Adverse effects, including neurological and cardiovascular issues, are more intense with SCs.
• Severe outcomes and addiction potential are significant concerns with SC use.

Conclusions:

• Synthetic cannabinoids present a dual profile of potent effects and significant risks.
• The scientific community is actively researching SCs for both their dangers and potential therapeutic applications.
• Further investigation is warranted to manage SC-related toxicity and explore cannabinoid therapeutics.